Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...
Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...
Service de chirurgie Orthopédique-Traumatologie - Hopital Sainte Marguerite, Marseille, France
Cleveland Clinic/Hillcrest Hospital, Mayfield Heights, Ohio, United States
Veterans Administration Hospital, West Haven, Connecticut, United States
Wesley Hospital, Sydney, New South Wales, Australia
Santa Casa de São Paulo, São Paulo, Brazil
St. Mary's Duluth Clinic Health System, Duluth, Minnesota, United States
University Hospital of Geneva, Geneva, Canton of Geneva, Switzerland
Children's Medical Center Dallas, University of Texas Southwestern, Dallas, Texas, United States
Arkansas Children's Hospital, Little Rock, Arkansas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.